Adam Scott Levy

CFO and Secretary

Adam Scott Levy (CFO and Secretary) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in Mineralys Therapeutics, Inc. (MLYS). The largest single filing was $5.3M of MLYS (116,948 sh across 7 lots, as filed), executed Nov 11 2025.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 3 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$6.1M

shares × price, as filed

Last traded

Jan 12

Filed Jan 13

Median ADV $38.0M across their filed names

Open performance→

Volume by month

Buys $0 Sells $7.5M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 3 filings

Sector per market data · by filing · past 12 months

Most traded names

MLYS Mineralys Therapeutics, Inc. MLYS · 0 buys · 7 sells 7 filings

Recent filings

MLYSSALE Mineralys Therapeutics, Inc. View filing → $346K
10,758 sh × $32.14
Exec Jan 12
Filed Jan 13 · 5:30 PM ET MLYSSALE Mineralys Therapeutics, Inc. View filing → $5.3M
116,948 sh across 7 lots
Exec Nov 11 2025
Filed Nov 13 2025 · 5:30 PM ET MLYSSALE Mineralys Therapeutics, Inc. View filing → $452K
10,758 sh across 2 lots
Exec Oct 13 2025
Filed Oct 15 2025 · 5:30 PM ET MLYSSALE Mineralys Therapeutics, Inc. View filing → $1.1M
72,871 sh across 3 lots
Exec Jul 28 2025
Filed Jul 30 2025 · 5:30 PM ET MLYSSALE Mineralys Therapeutics, Inc. View filing → $155K
10,758 sh × $14.45
Exec Jul 11 2025
Filed Jul 15 2025 · 5:30 PM ET MLYSSALE Mineralys Therapeutics, Inc. View filing → $130K
10,757 sh × $12.06
Exec Apr 11 2025
Filed Apr 15 2025 · 5:30 PM ET MLYSSALE Mineralys Therapeutics, Inc. View filing → $146K
10,757 sh × $13.57
Exec Oct 11 2024
Filed Oct 15 2024 · 5:30 PM ET